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Introduction
Renal involvement is a major cause of morbidity and
hospital admissions in systemic lupus erythematosus
(SLE) patients and occurs in 40% to 70% of all patients.
Generally, renal involvement tends to occur within the
first 2 years of SLE with its frequency decreasing signifi-
cantly after the first 5 years of disease.
Objectives
To describe and to compare the clinical features and
disease activity of a cohort of patients with SLE at a
Colombian children’s hospital in two different moments.
Methods
Analytic descriptive study. 89 patients with diagnosis of
SLE (1997 ACR revised criteria) from a rheumatology
center at a pediatric hospital were evaluated at the time
of diagnosis and twelve months after. Medical records
were reviewed registering the following variables: Sex,
age, renal involvement1 (Yes/No), hypertension (Yes/
No), nephrotic range proteinuria1 (Yes/No), renal biopsy
(Yes/No), histological classification of lupus nephritis
(HCLN) (International Society of Nephrology/Renal
Pathology Society, 2003), dialysis (Yes/No), and score
Systemic Lupus Erythematosus Disease Activity Index
(SLEDAI). Analysis was done through parametric and
non parametric tests to compare means and propor-
tions, using STATA11.
Results
76 patients (85.4%) were female and 13 (14.6%) were men.
Mean age at the time of diagnosis was 11,3 years old (Min
2, Max 16). Renal involvement at the time of diagnosis
was found in 73 patients (82%); after 12 months it was
found in 68 patients (76,4%) (p < 0,01), hypertension at
the time of diagnosis was found in 30 patients (41,1%);
after 12 months it was found in 8 patients (11%) (p <
0,01), nephrotic range proteinuria at the time of diagnosis
was found in 15 patients (20,5%); after 12 months it was
found in 8 patients (11%) (p < 0,01), 36 patients (49,3%)
underwent renal biopsy, 16 patients (44,4%) underwent a
second renal biopsy, HCLN first biopsy: Class I (8,3%),
Class II (11,1%), Class III (8,3%), Class IV (50%), Class V
(13,9%), Class III-IV (5,6%), HCLN second biopsy: Class I
(6,3%), Class III (6,3%), Class IV (62,5%), Class V (25%),
Class IV-V (12,5%), patients on dialysis at the time of diag-
nosis were 1 (1,4%); after 12 months they were 3 (4,4%)
(p = 0,36), and median score SLEDAI at the time of diag-
nosis was 23 (Min 4, Max 61); after 12 months it was 4
(Min 0, Max 31) (p < 0,01).
Conclusion
The most common HCLN in this cohort were Class IV,
and Class V. Statistical significance (difference) was
documented regarding renal involvement, hypertension,
nephrotic range proteinuria, and median score SLEDAI
for the time of diagnosis and twelve months follow-up.
This suggests that the change and improvement in clini-
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